A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.
Jamie Michele JacobsKathryn PostKatina MassadNora K HorickEmily A WalshJulia CohnChelsea S RapoportAmy J ClaraMichael H AntoniSteven A SafrenAnn H PartridgeJeffrey M PeppercornElyse R ParkJennifer S TemelJoseph Andrew GreerPublished in: Cancer (2022)
Patients taking adjuvant endocrine therapy (AET) after breast cancer may face challenges while following their treatment regimen. In this randomized controlled trial of 100 patients taking AET, a brief, small-group virtual intervention (STRIDE) was well-received by patients and led to improvements in how upset patients were due to symptoms, how confident they were in managing symptoms, and how well they could cope with stress. Thus, STRIDE is a promising intervention and should be tested in future multi-site trials.
Keyphrases
- randomized controlled trial
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- clinical trial
- type diabetes
- adipose tissue
- physical activity
- metabolic syndrome
- bone marrow
- study protocol
- insulin resistance
- heat stress
- glycemic control
- current status